Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Administration of Methylprednisolone + Prednisone + Mycophenolate mofetil[3] Methylprednisolone (Methylprednisolone acetate),
Mycophenolate mofetil,
Prednisone
[5] Methylprednisolone (Methylprednisolone),
Prednisone ,
Mycophenolate mofetil ,
Methylprednisolone acetate (Methylprednisolone acetate),
Mycophenolate mofetil hydrochloride 💬
[3] IMPDH1,
IMPDH2,
NR3C1 💬
[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 49 💬
2Administration of methylprednisolone, paracetamol and dexchlorpheniramine[2] Dexchlorpheniramine,
Methylprednisolone (Methylprednisolone acetate)
[3] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate),
Dexchlorpheniramine 💬
[2] HRH1,
NR3C1 💬
[4] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬[1] 49 💬
3Administration of rituximab and methylprednisolone[2] Methylprednisolone (Methylprednisolone acetate),
Rituximab
[3] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate),
Rituximab 💬
[2] MS4A1,
NR3C1 💬
[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 51 💬
4Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E , K + imipenem or meropenem[4] Imipenem,
Meropenem,
Methylprednisolone (Methylprednisolone acetate),
Ursodeoxycholic acid
[7] Imipenem ,
Methylprednisolone (Methylprednisolone),
Ursodiol ,
Methylprednisolone acetate (Methylprednisolone acetate),
Meropenem ,
Imipenem ,
Meropenem 💬
[2] NR1H4,
NR3C1 💬
[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 296 💬
5Corticosteroid treatment (Methylprednisolone or prednisolone)[2] Methylprednisolone (Methylprednisolone acetate),
Prednisolone
[3] Methylprednisolone (Methylprednisolone),
Prednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 64 💬
6Cyclophosphamide, Azathioprine,prednisone,methylprednisolone[4] Azathioprine,
Cyclophosphamide,
Methylprednisolone (Methylprednisolone acetate),
Prednisone
[7] Azathioprine ,
Cyclophosphamide ,
Methylprednisolone (Methylprednisolone),
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate),
Azathioprine sodium ,
Cyclophosphamide 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
7High-dose intravenous methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
8Infliximab, methylprednisolone, methotrexate[3] Infliximab,
Methotrexate,
Methylprednisolone (Methylprednisolone acetate)
[5] Methotrexate ,
Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate),
Methotrexate sodium ,
Infliximab 💬
[4] DHFR,
DHFR2,
NR3C1,
TNF 💬
[70] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Folate transport and metabolism, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 46 💬
9Interferon-beta-1a (Avonex) plus methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
10Intravenous (i.v.) methylprednisolone 1000 mg, total 9[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 222, 223 💬
11Intravenous Methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 97, 145 💬
12Intravenous Methylprednisolone (IVMP)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
13Intravenous methylprednisolone (IVMP) and Efgartigimod[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
14IV methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
15IV methylprednisolone (steroids)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
16Megadose oral methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
17Methotrexate + Methylprednisolone[2] Methotrexate,
Methylprednisolone (Methylprednisolone acetate)
[4] Methotrexate ,
Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate),
Methotrexate sodium 💬
[3] DHFR,
DHFR2,
NR3C1 💬
[4] Folate biosynthesis, Folate transport and metabolism, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬[1] 46 💬
18Methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[51] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
19Methylprednisolone (Corticosteroid)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 49 💬
20Methylprednisolone (drug)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
21Methylprednisolone (MP)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 60, 65, 285 💬
22Methylprednisolone (MP) or prednisone (pred)[2] Methylprednisolone (Methylprednisolone acetate),
Prednisone
[3] Methylprednisolone (Methylprednisolone),
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
23Methylprednisolone (or other glucocorticoid)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
24Methylprednisolone (Solu-Medrol)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 14 💬
25Methylprednisolone 1250 mg/24h x3 days[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
26METHYLPREDNISOLONE ACETATE[2] Acetate,
Methylprednisolone (Methylprednisolone acetate)
[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 46, 51 💬
27Methylprednisolone and azathioprine[2] Azathioprine,
Methylprednisolone (Methylprednisolone acetate)
[4] Azathioprine ,
Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate),
Azathioprine sodium 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 93, 95 💬
28Methylprednisolone and IVIG[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 63 💬
29Methylprednisolone and Mycophenolate mofetil[2] Methylprednisolone (Methylprednisolone acetate),
Mycophenolate mofetil
[4] Methylprednisolone (Methylprednisolone),
Mycophenolate mofetil ,
Methylprednisolone acetate (Methylprednisolone acetate),
Mycophenolate mofetil hydrochloride 💬
[3] IMPDH1,
IMPDH2,
NR3C1 💬
[3] Drug metabolism - other enzymes, Neuroactive ligand-receptor interaction, Purine metabolism 💬[2] 93, 95 💬
30Methylprednisolone bolus IV 15 mg/kg/d for 3 days.[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 84 💬
31Methylprednisolone hemisuccinate[2] Methylprednisolone (Methylprednisolone acetate),
Methylprednisolone hemisuccinate (Methylprednisolone hydrogen succinate)
[4] Methylprednisolone (Methylprednisolone),
Methylprednisolone sodium succinate (Methylprednisolone sodium succinate, SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT),
Methylprednisolone acetate (Methylprednisolone acetate),
Methylprednisolone hemisuccinate (Methylprednisolone hemisuccinate, Methylprednisolone succinate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 85 💬
32Methylprednisolone IV[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
33METHYLPREDNISOLONE MYLAN Générique[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 66 💬
34Methylprednisolone or budesonide[2] Budesonide,
Methylprednisolone (Methylprednisolone acetate)
[3] Budesonide ,
Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 96 💬
35Methylprednisolone or Prednisolone[2] Methylprednisolone (Methylprednisolone acetate),
Prednisolone
[3] Methylprednisolone (Methylprednisolone),
Prednisolone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 65 💬
36Methylprednisolone PO[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
37Methylprednisolone pulse[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
38Methylprednisolone pulses plus prednisone versus Cyclosporine A[3] Cyclosporine,
Methylprednisolone (Methylprednisolone acetate),
Prednisone
[4] Cyclosporine ,
Methylprednisolone (Methylprednisolone),
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[6] NR3C1,
PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[34] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Neuroactive ligand-receptor interaction, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 223 💬
39METHYLPREDNISOLONE SODIUM HEMISUCCINATE[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 13, 85, 97 💬
40METHYLPREDNISOLONE SODIUM SUCCINATE[3] Methylprednisolone (Methylprednisolone acetate),
Methylprednisolone hemisuccinate (Methylprednisolone hydrogen succinate),
Succinic acid
[4] Methylprednisolone (Methylprednisolone),
Methylprednisolone sodium succinate (Methylprednisolone sodium succinate, SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT),
Methylprednisolone acetate (Methylprednisolone acetate),
Methylprednisolone hemisuccinate (Methylprednisolone hemisuccinate, Methylprednisolone succinate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[7] 13, 46, 49, 50, 51, 211, 222 💬
41Methylprednisolone succinate[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 13, 66 💬
42Methylprednisolone(intravenously in the 1st-2nd-3rd month )[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
43Methylprednisolone(intravenously in the 1st-3rd-5th month)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 66, 223 💬
44Nasal Methylprednisolone (MT)[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
45Oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
46Oral Methylprednisolone 625 mg/24h x3 days[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
47Other: Exposure to methylprednisolone during pregnancy[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
48Other: IV Methylprednisolone administration[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
49Prednisone (and methylprednisolone)[2] Methylprednisolone (Methylprednisolone acetate),
Prednisone
[3] Methylprednisolone (Methylprednisolone),
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 43 💬
50Prednisone, methylprednisolone,cyclophosphamides[2] Methylprednisolone (Methylprednisolone acetate),
Prednisone
[3] Methylprednisolone (Methylprednisolone),
Prednisone ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 42, 43, 45 💬
51Preventative (Prophylactic) Medication - Corticosteroids: Methylprednisolone[1] Methylprednisolone (Methylprednisolone acetate)[2] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 2 💬
52Rituximab plus methylprednisolone[2] Methylprednisolone (Methylprednisolone acetate),
Rituximab
[3] Methylprednisolone (Methylprednisolone),
Methylprednisolone acetate (Methylprednisolone acetate),
Rituximab 💬
[2] MS4A1,
NR3C1 💬
[2] Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬[1] 63 💬
53Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone)[2] Methylprednisolone (Methylprednisolone acetate),
Ursodeoxycholic acid
[3] Methylprednisolone (Methylprednisolone),
Ursodiol ,
Methylprednisolone acetate (Methylprednisolone acetate) 💬
[2] NR1H4,
NR3C1 💬
[2] Bile secretion, Neuroactive ligand-receptor interaction 💬[1] 93 💬